Get the Stockscreener App
25.26
0.00%
0.00
After Hours:
25.26
Precipio Inc stock is traded at $25.26, with a volume of 62,608.
It is up +0.00% in the last 24 hours and up +7.54% over the past month.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
See More
Previous Close:
$25.26
Open:
$24.65
24h Volume:
62,608
Relative Volume:
1.88
Market Cap:
$45.15M
Revenue:
$24.05M
Net Income/Loss:
$-363.00K
P/E Ratio:
-85.66
EPS:
-0.2949
Net Cash Flow:
$359.00K
1W Performance:
+4.04%
1M Performance:
+7.54%
6M Performance:
+9.92%
1Y Performance:
+109.63%
1-Day Range:
$24.29
$25.26
1-Week Range:
$22.26
$25.94
52-Week Range:
$12.46
$33.63
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, IDXX, NTRA, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
25.26 | 44.26M | 24.05M | -363.00K | 359.00K | -0.2949 |
TMO
Thermo Fisher Scientific Inc
|
517.60 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
193.62 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
564.98 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
283.80 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
378.89 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Precipio Inc Stock (PRPO) Latest News
Why (PRPO) Price Action Is Critical for Tactical Trading - Stock Traders Daily
The Zacks Analyst Blog Highlights Caterpillar, Palo Alto Networks, Toyota Motor and Precipio - Yahoo Finance
Precipio, Inc.(NasdaqCM: PRPO) added to Russell 3000E Index - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell 3000E Growth Benchmark - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Price to sales forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Enterprise value to revenue forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Precipio, Inc. Actuals & Estimates (NASDAQ:PRPO) - TradingView
Precipio Inc (PRPO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Understanding Momentum Shifts in (PRPO) - Stock Traders Daily
Precipio Inc (PRPO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Precipio Inc (PRPO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precipio Inc (PRPO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Precipio Inc (PRPO) Institutional Confidence - TradingKey
Precipio Inc (PRPO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precipio Inc (PRPO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Precipio Inc (PRPO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Precipio Inc (PRPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PRPO: Rapid, profitable growth driven by innovative four-hour cancer diagnostics and scalable operations - TradingView
PRPO: Rapid, profitable growth driven by innovative diagnostics and strong customer retention - TradingView
Precipio (PRPO) AGM 2026 Summary - Quartr
Precipio Shareholders Back Board Nominees and Auditor - TipRanks
[8-K] Precipio, Inc. Reports Material Event - Stock Titan
Precipio to Present at the Planet MicroCap Las Vegas - The National Law Review
Precipio Inc Annual Shareholders Meeting Transcript - GuruFocus
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS Achieved Amid Stock DeclineEBITDA Analysis - newsline.com
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting - The Manila Times
Precipio urges shareholders to vote ahead of Saturday meeting - Investing.com
Precipio urges shareholders to vote ahead of Saturday meeting By Investing.com - Investing.com Australia
Lack of quorum may force costly delay of Precipio shareholder meeting - Stock Titan
Cancer diagnostics firm Precipio heads to Vegas for Planet MicroCap 2026 - Stock Titan
Avoiding Lag: Real-Time Signals in (PRPO) Movement - Stock Traders Daily
Precipio Inc. (PRPO) Edges Higher Amid Consolidation Near ResistanceShort Setup Alerts - newsline.com
Precipio Inc. (PRPO) Edges Higher as Stock Nears ResistanceSell Signal Alerts - newsline.com
Precipio (PRPO) Q1 2026 Earnings Call Transcript - AOL.com
Precipio Q2 2025 Earnings: Positive EPS Marks a Milestone Despite Market ReactionMargin Compression Risk - newsline.com
Precipio (PRPO) Q4 2025 Earnings Transcript - AOL.com
PRPO Q2 2025 Earnings: Profitable Quarter Achieved Despite Revenue UncertaintyRevenue Breakdown Analysis - newsline.com
Discipline and Rules-Based Execution in PRPO Response - Stock Traders Daily
PRPO Q2 2025 Earnings: Positive EPS Marks a Turning Point for Diagnostic PlatformEarnings Growth Forecast - The Legal Advocate
Precipio director Richard Sandberg sells $22,517 in common stock By Investing.com - Investing.com Nigeria
Precipio director Richard Sandberg sells $22,517 in common stock - Investing.com
Precipio (PRPO) director-linked entity reports 900-share open-market sale - Stock Titan
Number of shareholders of Precipio, Inc. – GETTEX:TGK - TradingView
PRPOPrecipio Inc Stock Price and Quote - Finviz
Precipio Q2 2025 Earnings: Company Reports Positive EPS of $0.05; Stock Declines 3.09%Growth Acceleration Report - thelegaladvocate.com
Precipio Inc. (PRPO) Q2 2025 Earnings: Unexpected Profitability Amid Revenue ChallengesEPS Growth Report - newsline.com
Precipio Stock Slides Before Holiday — Why Tuesday’s Open Matters - Bez Kabli
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precipio Inc Stock (PRPO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SANDBERG RICHARD A | Director |
May 20 '26 |
Sale |
24.89 |
2,034 |
50,632 |
8,142 |
| SANDBERG RICHARD A | Director |
May 19 '26 |
Sale |
24.42 |
600 |
14,652 |
4,400 |
| SANDBERG RICHARD A | Director |
May 20 '26 |
Sale |
25.00 |
500 |
12,500 |
3,900 |
1.05%
2.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):